Journals / Türk Beyin Damar Hastalıkları Dergisi / 2001 / Cilt: 7 - Sayı: 1

Homozygous factor V Leiden mutation and ischemic stroke

Homozigot Faktör V Leiden mutasyonu ve iskemik inme

Pages
25–27
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This mutation can favour thrombosis irrespective of the underlying stroke etiology or can be an independent etiological factor especially in homozygous individuals as in our case.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Factor V Leiden mutation is the most common cause of inherited thrombophilia.
📊
Key Findings & Data:A 49 years old female patient with history of epilepsia, deep vein thrombosis, pulmonary embolism and left hemiparesis was admitted because of forgetfulness and attentional difficulties.
💡
Conclusion & Impact:This mutation can favour thrombosis irrespective of the underlying stroke etiology or can be an independent etiological factor especially in homozygous individuals as in our case.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Nokta mutasyonu · Homozigot · Faktör V

Abstract

Factor V Leiden mutation is the most common cause of inherited thrombophilia. Its potential role in arterial thrombosis is still debated. A 49 years old female patient with history of epilepsia, deep vein thrombosis, pulmonary embolism and left hemiparesis was admitted because of forgetfulness and attentional difficulties. Cranial MRI examinations showed multiple symptomatic and asymptomatic brain infarcts. A detailed etiological evaluation revealed only a homozygous factor V Leiden mutation. Four of the siblings who were analysed were carrying the mutation and 3 of them were homozygous. This mutation can favour thrombosis irrespective of the underlying stroke etiology or can be an independent etiological factor especially in homozygous individuals as in our case.

Özet

Faktör V Leiden mutasyonu en sık rastlanılan herediter trombofili nedenidir. Arteryel tıkayıcı olaylarla ilişkisi tartışmalıdır. Kırk dokuz yaşındaki kadın hasta unutkanlık ve dikkat eksikliği nedeniyle başvurdu. Özgeçmişinde epileptik nöbetler, derin ven trombozu, pulmoner emboli ve sol hemiparezi öyküsü vardı. Kranyal MRG'de birçok semptoma tik ve asemptomatik beyin infarktı görüldü. Ayrıntılı etiolojik incelemelerinde homozigot faktör V Leiden mutasyonu dışında bir özellik ortaya konulamadı. Ailenin incelenebilen diğer 4 bireyi de bu mutasyonu taşımaktaydı ve 3'ü homozigottu. Bu mutasyonun altta yatan neden ne olursa olsun inme gelişimini kolaylaştırıcı bir etken rolü oynayabileceği veya bizim olgumuzda olduğu gibi özellikle homozigot bireylerde başlı başına bir inme nedeni olabileceği öne sürülebilir.

🔖

Cite This Article

KRESPİ, Y., MATUR, Z., ÇOBAN, O., TUNÇAY, R., BAHAR, S. (2001). Homozygous factor V Leiden mutation and ischemic stroke. Türk Beyin Damar Hastalıkları Dergisi, Cilt: 7 - Sayı: 1, 25–27. https://ajindex.com/articles/399066

References (12)

  1. Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med. 1994;330:517-522
  2. Bontempo FA, Hassett AC, Faruki H, Steed DL, Webster MW, Makaroun MS. The factor V Leiden mutation: spectrum of thrombotic events and laboratory evaluation. J Vase Surg 1997;25{2):271-275
  3. Martinelli I, Mannucci PM; De Stefano V, Taioli E, Rossi V, Crosti, Paciaroni K, Leone G, Faioni EM. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood 1998;92:2353-2358
  4. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-67
  5. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and woman. JAMA 1997;277(16):1305-1307
  6. Simioni P, de Ronde H, Prandoni P, Saladini M, Bertina RM, Girolami A. ıschemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. Stroke 1995;26(5):885-890
  7. De Lucia D, Nina P, Papa ML, Belli A, Conte M, Renis V, Di Mauro C, Masi S, Franco A, Schisano G. Activated protein C resistance due to a factor V mutation associated with familial ischemic stroke. J Neurosurg Sci 1997;41(4): 373-378
  8. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous trombosis in apparently healty men. New Engl J Med 1995;32:912-917
  9. Press RD, Liu XY, Beamer N, Coull BM. ıschemic stroke in the elderly. Role of the common factor V mutation causing resistance to activated protein C. Stroke 1996;27(l}:44-48
  10. Kontula K, Ylikorkala A, Miettinen H, Vuorio A, Kauppinen-Makelin R, Hamalainen L, Palomaki H, Kaste M. Arg506Gln factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction. Thromb Haemost 1995;73(4):558-560
  11. Gaustadnes M, Rudiger N, Moller J, Rasmussen K, Bjerregaard Larsen T, ıngerslev J. Thrombophilic predisposition in stroke and venous thromboembolism in Danish patients. Blood Coagul Fibrinolysis 1999;10(5):251-259
  12. Iniesta JA, Corral J, Fernandez-Pardo J, Gonzalez-Conejero R, Vicente V. Factor V (Arg506$ddagger$Gln) mutation in ischemic cerebrovascular disease.